Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2894 | 2311 | 29.7 | 48% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
198 | 48841 | CELLULAR IMMUNOLOGY//THYMOSIN BETA 4//INTERLEUKIN 2 |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
17480 | 533 | IMMUNE SUPPRESSOR CELLS//IRX 2//SERV 151Z2 |
19739 | 427 | BOVINE BETALACTOGLOBULIN//MUCOSAL ANTIGENS//BR AMBEDKAR ROTARY CANC HOSP |
19892 | 421 | P15E//CKS 17//ADV MED TREATMENTS |
25159 | 241 | POSTOPERATIVE SEPTIC COMPLICATIONS//BRIAN MIND//LOOSENING OF ENDOPROSTHESES |
25361 | 235 | WHOLE BLOOD CELL CULTURES//COLORIMETRY METHOD//HUMAN COLORECTAL TUMORS |
29048 | 158 | CHIMERIC ANTIBODY 311//COLON CANCER ANTIGENS//HJ TAGNON |
31135 | 127 | CYCLIC POLYLACTATE//RABDOMYOSARCOMA//CARCINOID SYNDROM |
33054 | 98 | MED CHILDRENS HOSP FDN//PEDIAT SURG 219 BRYANT ST//PESQUISA SOBRE TIMO |
34431 | 71 | 2HB ANTIGEN//CIENCIAS BIOQUIM ARTADO 644//DELAYED HYPERSENSITIVITY SKIN TEST |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | P15E | Author keyword | 21 | 90% | 0% | 9 |
2 | IMMUNE SUPPRESSOR CELLS | Author keyword | 14 | 100% | 0% | 7 |
3 | IRX 2 | Author keyword | 11 | 67% | 0% | 10 |
4 | CKS 17 | Author keyword | 6 | 80% | 0% | 4 |
5 | SERV 151Z2 | Address | 5 | 50% | 0% | 7 |
6 | POSTOPERATIVE SEPTIC COMPLICATIONS | Author keyword | 4 | 67% | 0% | 4 |
7 | CYCLIC POLYLACTATE | Author keyword | 3 | 100% | 0% | 3 |
8 | TUMOR BEARERS | Author keyword | 2 | 67% | 0% | 2 |
9 | WHOLE BLOOD CELL CULTURES | Author keyword | 2 | 40% | 0% | 4 |
10 | ADV MED TREATMENTS | Address | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | P15E | 21 | 90% | 0% | 9 | Search P15E | Search P15E |
2 | IMMUNE SUPPRESSOR CELLS | 14 | 100% | 0% | 7 | Search IMMUNE+SUPPRESSOR+CELLS | Search IMMUNE+SUPPRESSOR+CELLS |
3 | IRX 2 | 11 | 67% | 0% | 10 | Search IRX+2 | Search IRX+2 |
4 | CKS 17 | 6 | 80% | 0% | 4 | Search CKS+17 | Search CKS+17 |
5 | POSTOPERATIVE SEPTIC COMPLICATIONS | 4 | 67% | 0% | 4 | Search POSTOPERATIVE+SEPTIC+COMPLICATIONS | Search POSTOPERATIVE+SEPTIC+COMPLICATIONS |
6 | CYCLIC POLYLACTATE | 3 | 100% | 0% | 3 | Search CYCLIC+POLYLACTATE | Search CYCLIC+POLYLACTATE |
7 | TUMOR BEARERS | 2 | 67% | 0% | 2 | Search TUMOR+BEARERS | Search TUMOR+BEARERS |
8 | WHOLE BLOOD CELL CULTURES | 2 | 40% | 0% | 4 | Search WHOLE+BLOOD+CELL+CULTURES | Search WHOLE+BLOOD+CELL+CULTURES |
9 | BOVINE BETALACTOGLOBULIN | 1 | 100% | 0% | 2 | Search BOVINE+BETALACTOGLOBULIN | Search BOVINE+BETALACTOGLOBULIN |
10 | GLUCOCORTICOID REGULATED GENES | 1 | 50% | 0% | 2 | Search GLUCOCORTICOID+REGULATED+GENES | Search GLUCOCORTICOID+REGULATED+GENES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CYTOKINE MIXTURE IRX 2 | 17 | 100% | 0% | 8 |
2 | P15E | 10 | 61% | 0% | 11 |
3 | MULTITEST CMI | 7 | 67% | 0% | 6 |
4 | PERILYMPHATIC INTERLEUKIN 2 | 6 | 80% | 0% | 4 |
5 | B16 BL6 MELANOMA | 6 | 71% | 0% | 5 |
6 | MONONUCLEAR PHAGOCYTE FUNCTION | 6 | 47% | 0% | 9 |
7 | RETROVIRAL PROTEIN | 6 | 100% | 0% | 4 |
8 | IMMUNE SUPPRESSOR CELLS | 4 | 67% | 0% | 4 |
9 | PULSE THERAPY SCHEDULE | 4 | 67% | 0% | 4 |
10 | TAA | 4 | 67% | 0% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Cytokines in head and neck cancer | 2006 | 48 | 51 | 41% |
IMMUNOSUPPRESSIVE ACTIVITY OF THE RETROVIRAL ENVELOPE PROTEIN-P15E AND ITS POSSIBLE RELATIONSHIP TO NEOPLASIA | 1984 | 128 | 17 | 59% |
Protective mechanisms of head and neck squamous cell carcinomas from immune assault | 2006 | 38 | 88 | 32% |
IMMUNOSUPPRESSIVE RETROVIRAL PEPTIDES - CAMP AND CYTOKINE PATTERNS | 1995 | 120 | 91 | 29% |
Adjuvant breast cancer vaccine improves disease specific survival of breast cancer patients with depressed lymphocyte immunity | 2013 | 5 | 18 | 33% |
IMMUNOSUPPRESSIVE FACTORS IN HUMAN CANCER | 1993 | 143 | 156 | 19% |
Immunosuppressive retroviral peptides: Immunopathological implications for immunosuppressive influences of retroviral infections | 1997 | 43 | 125 | 50% |
Non-steroidal anti-inflammatory drugs, tumour immunity and immunotherapy | 2012 | 14 | 143 | 17% |
Role of cytokines in head and neck squamous cell carcinoma | 2006 | 25 | 88 | 31% |
Covalent linking of proteins and cytokines to suture: Enhancing the immune response of head and neck cancer patients | 2003 | 9 | 105 | 64% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SERV 151Z2 | 5 | 50% | 0.3% | 7 |
2 | ADV MED TREATMENTS | 1 | 100% | 0.1% | 2 |
3 | OTOLARYNGOL HEAD NECK SURG CANC | 1 | 50% | 0.1% | 2 |
4 | SERV 151 Z2 | 1 | 33% | 0.1% | 2 |
5 | ALLGEMEINE EXPTL PATHOL MOLEK BIOL ABT | 1 | 50% | 0.0% | 1 |
6 | BR AMBEDKAR ROTARY CANC HOSP | 1 | 50% | 0.0% | 1 |
7 | BRIAN MIND | 1 | 50% | 0.0% | 1 |
8 | CELLNETIX PATHOL | 1 | 50% | 0.0% | 1 |
9 | CIENCIAS BIOQUIM ARTADO 644 | 1 | 50% | 0.0% | 1 |
10 | HJ TAGNON | 1 | 50% | 0.0% | 1 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000029491 | TUMOR DORMANCY//DORN VA MED//CONCOMITANT RESISTANCE |
2 | 0.0000025911 | EOSINOPHIL CHEMOTACTIC FACTOR//LEUKOREGULIN//RYBINSK RESERVOIR |
3 | 0.0000025543 | INTERLEUKIN 2//GRANZYME B//PERFORIN |
4 | 0.0000023826 | JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY//MANNOSE RECEPTOR//ENDO180 |
5 | 0.0000014808 | IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY |
6 | 0.0000014482 | EXPERIMENTAL LEPROSY//IGA ALPHA 1 ANTITRYPSIN COMPLEX//IGA ALPHA1 ANTITRYPSIN COMPLEX |
7 | 0.0000013985 | IMEXON//LEVAMISOLE//TYROSERLEUTIDE |
8 | 0.0000013905 | THYMOSIN BETA 4//PROTHYMOSIN ALPHA//THYMOSIN ALPHA 1 |
9 | 0.0000011792 | UKRAIN//ANTITUMOR RESISTANCE//RE KAVETSKY EXPT PATHOL ONCOL RADIOBIOL |
10 | 0.0000011251 | THYMUS//THYMIC NURSE CELLS//INTERLEUKIN 2 RECEPTOR |